ATYR
aTyr Pharma, Inc.
NASDAQ: ATYR · HEALTHCARE · BIOTECHNOLOGY
$0.81
+5.54% today
Updated 2026-04-30
Market cap
$79.17M
P/E ratio
—
P/S ratio
416.67x
EPS (TTM)
$-0.80
Dividend yield
—
52W range
$1 – $7
Volume
1.1M
aTyr Pharma, Inc. (ATYR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-11.38M | $-17.31M | $-22.82M | $-36.80M | $-52.86M | $-42.36M | $-31.06M | $-20.01M | $-15.30M | $-33.08M | $-41.89M | $-33.22M | $-69.12M | $-61.99M |
| Capital expenditures | $598000.00 | $644000.00 | $249000.00 | $664000.00 | $600000.00 | $1.31M | $594000.00 | $79000.00 | $202000.00 | $192000.00 | $1.64M | $4.21M | $65000.00 | $77000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $155000.00 | $1.79M | $4.86M | — | — | — | $1.78M | $1.47M | $1.61M | $2.15M | $2.60M | $2.99M | $5.00M |
| Free cash flow | $-11.98M | $-17.95M | $-23.07M | $-37.46M | $-53.46M | $-43.68M | $-31.66M | $-20.09M | $-15.50M | $-33.27M | $-43.53M | $-37.44M | $-69.18M | $-62.06M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — |